Deciphera Pharmaceuticals
Presença
Deciphera Pharmaceuticals é uma das ...
Deciphera Pharmaceuticals é uma empresa listada sob o símbolo DCPH (US).
Executivos
Veja o organograma con seus 23 executivos principais
Biografias mais buscadas da Deciphera Pharmaceuticals
- Steven Hoerter, Director, President and Chief Executive Officer
- John Martin, Director
- James Bristol, Chairman of the Board
Recentes movimentos de executivos em Deciphera Pharmaceuticals
- Daniel Flynn, Executive Vice President and Chief Scientific Officer, se aposentou (Notícia publicada em 4 de agosto de 2023).
- Dashyant Dhanak, ingressou na Companhia como Executive Vice President and Chief Scientific Officer (Notícia publicada em 4 de agosto de 2023).
Criar um alerta
para seguir os movimentos de executivos da Deciphera Pharmaceuticals.
Farmacêutica
Deciphera Pharmaceuticals possui 1.863 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- View more press releases Close
Redes sociais sobre Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Deciphera Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Steven Hoerter 
Ligue para a Deciphera Pharmaceuticals em +1 785...
